Status: Not yet recruiting
PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows
a Phase II, single-arm, open-label, multi-center study to evaluate safety, tolerability, pharmacokinetics, and the effectiveness of near-infrared fluorescence imaging during surgery.
Participants needed: 27
Trial details
Phase: Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: Haitao Niu, MDUpdated: Feb 4, 2026Locations: 1
Eligibility criteria
Subjects diagnosed with prostate cancer through preoperative transrectal prostat... [+6]
Subjects with a history of allergies (e.g., known allergies to two or more medic... [+4]